In parallel, we showed that even the optimized cutpoint for the preoperative PSA level was not superior in predicting BCR to the expression of functional markers involved in transcriptomic reprogramming that appeared to be significant in PC recurrence, as shown in previous studies [2,3]. This evidence concerns the gene KLK3 and pachyonychia congenita.